Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.8 | 1.88 |
NAV | ₹516.82 | ₹39.92 |
Fund Started | 10 May 2004 | 25 Jun 2018 |
Fund Size | ₹8569.15 Cr | ₹5727.59 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.8
1.88
NAV
₹516.82
₹39.92
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹8569.15 Cr
₹5727.59 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 5.16% | 11.35% |
3 Year | 23.28% | 27.76% |
5 Year | 19.57% | 22.02% |
1 Year
5.16%
11.35%
3 Year
23.28%
27.76%
5 Year
19.57%
22.02%
Holding Analysis
Equity | 99.43% | 96.45% |
Cash | 0.57% | 3.55% |
Equity
99.43%
96.45%
Cash
0.57%
3.55%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.23% |
Divi's Laboratories Ltd. | 8.50% |
Lupin Ltd. | 6.07% |
Cipla Ltd. | 5.62% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Dr. Reddy's Laboratories Ltd. | 5.18% |
Medplus Health Services Ltd. | 3.83% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.63% |
Narayana Hrudayalaya Ltd. | 3.55% |
Vijaya Diagnostic Centre Ltd. | 3.32% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.23% |
Divi's Laboratories Ltd. | 8.95% |
Dr. Reddy's Laboratories Ltd. | 8.92% |
Cipla Ltd. | 7.75% |
Aurobindo Pharma Ltd. | 6.06% |
Biocon Ltd. | 5.02% |
Mankind Pharma Ltd. | 4.20% |
Alkem Laboratories Ltd. | 4.01% |
Lupin Ltd. | 3.79% |
Gland Pharma Ltd. | 3.57% |
Fund Manager
Name | Akshay Sharma | Dharmesh Kakkad |
Start Date | 01 Dec 2022 | 23 Feb 2021 |
Name
Akshay Sharma
Dharmesh Kakkad
Start Date
01 Dec 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 10 May 2004 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
